Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Candela

This article was originally published in The Gray Sheet

Executive Summary

Medical and cosmetic laser manufacturer cites disagreement over final price and financing terms in calling off a March proposed deal with Advanced Medical Alliance related to the sale of Candela's Boston and Scottsdale, Arizona skin care centers. "We worked long and hard to reach a definitive agreement with the potential purchaser, but we found that both price and financial terms were not going to be in the best interest of our shareholders," Candela President and CEO Gerard Puorro remarks in a June 24 release. Earlier this year Candela booked a $2.6 mil. restructuring charge to second quarter earnings to close the Scottsdale facility ("The Gray Sheet" Jan. 26, p. 15). The financial performance of Candela's Boston center "continue to improve," Puorro notes...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel